UNSPSC 51131907: Human plasma protein fraction

This classification denotes a protein-based fluid (sometimes also called simulated body fluid) or that residual portion of blood that is left after removal of blood cells by centrifugation without prior blood coagulation, and proteins extracted therefrom, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6D53G0FD0Z. European Medicines Agency schedules Human Plasma Protein Fraction in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB51727 and SUB22285 and SUB32334.

UNSPSC 51131907 Human plasma protein fraction is a Commodity code representing a blood-derived therapeutic product that state and local health systems, hospitals, and emergency services procure for acute medical treatment. The code covers human plasma protein fractions — concentrated preparations of proteins extracted from pooled human plasma — used primarily in trauma care, burn treatment, hemorrhagic shock, and other acute conditions requiring rapid volume expansion and protein replacement. State and local procurement of this product is driven by hospital formulary needs, emergency department stocking requirements, and public health agency reserves for mass-casualty events.

The source provided contains no recent state and local contract opportunities tagged to this code, making current market activity and issuing-body patterns unavailable for evaluation. Without recent solicitation data, geographic concentration, representative RFP or IFB notices, or response dates, pursuit of opportunities under this code cannot be assessed against current procurement signals. Monitor state health department supply chain procurement channels and hospital cooperative purchasing groups — such as regional hospital purchasing consortia or state medicaid agency formulary acquisitions — for future activity, as procurement of blood-derived therapeutics typically moves through specialized medical supply and pharmacy vendor networks rather than general-market state and local solicitations.